Completed
A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Non-fasting Conditions
NCT00863863
- Conditions
- Healthy
- Locations
-
- Biovail Contract Research (A Division of Biovail Corporation) Toronto, Ontario, Canada